GLP-1 Companion Nutrition Market
完整報告名稱與涵蓋範圍
GLP-1 Companion Nutrition Market Size, Share & Trends Analysis Report, By Product Type (High-Protein Shakes, Bars and Ready Meals, Fiber, Electrolyte and Digestive Support Products, Micronutrient, Muscle Preservation and Bone Health Supplements, Portion-Controlled and Appetite-Aligned Food Ranges), By Format (Ready-to-Drink and Powdered Beverages, Snacks, Bars and Meals, Capsules, Gummies and Sachets), By Distribution Channel (Retail and Mass Merchandisers, Online, Direct-to-Consumer and Telehealth Bundles, Pharmacies and Clinical Programs), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The GLP-1 companion nutrition market covers high-protein shakes, bars and meals, fiber, electrolyte and digestive support products, micronutrient, muscle and bone health supplements and portion-controlled food ranges formulated and marketed for people using incretin-based weight loss and diabetes medicines, sold through retail, online and telehealth bundles and clinical programs. General weight management foods without GLP-1 positioning, the incretin drugs themselves and digital obesity platforms addressed in a separate InsightAce study are excluded.
The category emerged as tens of millions of people started incretin therapy and experienced reduced appetite, nausea, muscle loss and nutrient gaps that conventional diets do not address, prompting food, beverage and supplement companies to launch products positioned for smaller portions, higher protein and digestive comfort. Demand is driven by the scale of GLP-1 prescribing, by clinician and telehealth recommendations on protein intake and muscle preservation, by retailer shelf sets dedicated to GLP-1 consumers and by consumer packaged goods companies seeking growth as overall food volumes fall among medicated users. Claims regulation, the durability of demand as patients cycle on and off therapy, price sensitivity of long-term users and the entry of pharmaceutical companies and telehealth platforms with bundled nutrition shape competition.
North America leads through prescribing volumes and retail innovation, with Europe, Brazil, Australia and the Middle East following as therapy access expands. Competition involves global food and beverage groups, nutrition and supplement brands, weight management companies and telehealth platforms.
The InsightAce study provides US$ revenue forecasts for every product type, format, distribution channel and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GLP-1 Companion Nutrition Market Snapshot
Chapter 4. Global GLP-1 Companion Nutrition Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. High-Protein Shakes, Bars and Ready Meals
5.2.2. Fiber, Electrolyte and Digestive Support Products
5.2.3. Micronutrient, Muscle Preservation and Bone Health Supplements
5.2.4. Portion-Controlled and Appetite-Aligned Food Ranges
Chapter 6. Market Segmentation 2: By Format Estimates & Trend Analysis
6.1. Format & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Format:
6.2.1. Ready-to-Drink and Powdered Beverages
6.2.2. Snacks, Bars and Meals
6.2.3. Capsules, Gummies and Sachets
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
7.2.1. Retail and Mass Merchandisers
7.2.2. Online, Direct-to-Consumer and Telehealth Bundles
7.2.3. Pharmacies and Clinical Programs
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Consumers on GLP-1 Therapy
8.2.2. Healthcare Providers and Obesity Clinics
8.2.3. Employers and Health Plans
Chapter 9. GLP-1 Companion Nutrition Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Nestle S.A. (Vital Pursuit and Nestle Health Science)
11.2. Abbott Laboratories (Protality)
11.3. Danone S.A.
11.4. The Coca-Cola Company (Fairlife)
11.5. General Mills, Inc.
11.6. Conagra Brands, Inc.
11.7. Herbalife Ltd.
11.8. GNC Holdings
11.9. Ro (Roman Health Ventures Inc.)
11.10. WeightWatchers (WW International, Inc.)
11.11. Campofrio Food Group (Sigma Alimentos)
11.12. Kellanova
11.13. Simply Good Foods Company
11.14. Premier Protein (BellRing Brands, Inc.)
11.15. Nutrisystem (Kainos Capital)
圖表清單 List of Tables & Figures
Table 1. Global GLP-1 Companion Nutrition Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global GLP-1 Companion Nutrition Market Snapshot, 2026 & 2035
Table 2. Global GLP-1 Companion Nutrition Revenue Forecast by Format, 2026-2035 (US$ Mn)
Figure 2. Global GLP-1 Companion Nutrition Market Share by Format, 2026 & 2035
Table 3. Global GLP-1 Companion Nutrition Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 3. Nutritional Needs and Side Effects of GLP-1 Users Mapped to Companion Product Categories
Table 4. Global GLP-1 Companion Nutrition Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. GLP-1 User Population and Companion Nutrition Spending by Region, 2026-2035
Table 5. North America GLP-1 Companion Nutrition Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific GLP-1 Companion Nutrition Growth Opportunity Analysis
Table 6. Europe GLP-1 Companion Nutrition Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Retail, Telehealth and Clinical Channel Strategies for GLP-1 Nutrition Products
Table 7. Asia Pacific GLP-1 Companion Nutrition Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key GLP-1 Companion Nutrition Market Participants
Table 8. Latin America and Middle East & Africa GLP-1 Companion Nutrition Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們